Stephanie Wesolowski
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetus | 37 | 2025 | 782 | 5.170 |
Why?
| Liver | 28 | 2025 | 1839 | 5.000 |
Why?
| Sheep | 47 | 2025 | 845 | 4.530 |
Why?
| Fetal Growth Retardation | 29 | 2024 | 549 | 4.030 |
Why?
| Glucose | 24 | 2024 | 1003 | 3.970 |
Why?
| Diet, Western | 11 | 2025 | 79 | 2.840 |
Why?
| Placental Insufficiency | 15 | 2024 | 112 | 2.450 |
Why?
| Insulin | 31 | 2025 | 2330 | 2.390 |
Why?
| Liver Cirrhosis | 3 | 2025 | 281 | 2.240 |
Why?
| Pregnancy | 66 | 2025 | 6423 | 2.230 |
Why?
| Amino Acids | 15 | 2025 | 487 | 2.130 |
Why?
| Hypoxia | 7 | 2025 | 1087 | 1.970 |
Why?
| Fetal Hypoxia | 4 | 2025 | 54 | 1.870 |
Why?
| Prenatal Exposure Delayed Effects | 6 | 2025 | 573 | 1.690 |
Why?
| Maternal-Fetal Exchange | 5 | 2024 | 162 | 1.640 |
Why?
| Maternal Nutritional Physiological Phenomena | 4 | 2025 | 169 | 1.590 |
Why?
| Non-alcoholic Fatty Liver Disease | 4 | 2023 | 260 | 1.570 |
Why?
| Gluconeogenesis | 9 | 2025 | 78 | 1.530 |
Why?
| Metformin | 3 | 2024 | 316 | 1.490 |
Why?
| Muscle, Skeletal | 17 | 2023 | 1644 | 1.400 |
Why?
| Animals | 81 | 2025 | 35409 | 1.320 |
Why?
| Lactic Acid | 5 | 2024 | 304 | 1.250 |
Why?
| Fetal Development | 12 | 2024 | 287 | 1.240 |
Why?
| Insulin Resistance | 10 | 2023 | 1168 | 1.160 |
Why?
| Placenta | 10 | 2025 | 716 | 1.120 |
Why?
| Oxidation-Reduction | 7 | 2024 | 1031 | 1.120 |
Why?
| Pancreas | 7 | 2024 | 305 | 1.080 |
Why?
| Hyperinsulinism | 4 | 2020 | 119 | 1.010 |
Why?
| Placental Circulation | 4 | 2022 | 65 | 1.000 |
Why?
| Female | 78 | 2025 | 68829 | 0.860 |
Why?
| Bile Acids and Salts | 1 | 2025 | 195 | 0.840 |
Why?
| Leucine | 7 | 2022 | 109 | 0.800 |
Why?
| Glucose Clamp Technique | 4 | 2020 | 194 | 0.780 |
Why?
| Leukocytes | 1 | 2024 | 306 | 0.780 |
Why?
| Adipose Tissue | 5 | 2021 | 594 | 0.770 |
Why?
| Hypoglycemic Agents | 4 | 2024 | 1221 | 0.730 |
Why?
| Insulin-Secreting Cells | 5 | 2024 | 367 | 0.720 |
Why?
| Adaptation, Physiological | 3 | 2021 | 521 | 0.720 |
Why?
| Glucagon | 6 | 2025 | 105 | 0.680 |
Why?
| Disease Models, Animal | 11 | 2025 | 4077 | 0.680 |
Why?
| Primates | 5 | 2024 | 120 | 0.670 |
Why?
| Hepatocytes | 5 | 2024 | 215 | 0.630 |
Why?
| Islets of Langerhans | 7 | 2024 | 791 | 0.620 |
Why?
| Insulin-Like Growth Factor I | 6 | 2024 | 310 | 0.590 |
Why?
| AMP-Activated Protein Kinases | 3 | 2024 | 190 | 0.580 |
Why?
| Blood Glucose | 10 | 2025 | 2103 | 0.560 |
Why?
| Fetal Blood | 5 | 2024 | 318 | 0.550 |
Why?
| Pregnancy Complications | 2 | 2019 | 494 | 0.550 |
Why?
| Leptin | 5 | 2016 | 222 | 0.540 |
Why?
| Oxygen | 7 | 2023 | 916 | 0.510 |
Why?
| Lactation | 4 | 2024 | 175 | 0.510 |
Why?
| Gestational Age | 7 | 2024 | 876 | 0.510 |
Why?
| Energy Metabolism | 2 | 2021 | 875 | 0.440 |
Why?
| Myoblasts | 3 | 2021 | 84 | 0.420 |
Why?
| Mammary Glands, Animal | 3 | 2010 | 128 | 0.410 |
Why?
| Lipid Metabolism | 6 | 2024 | 503 | 0.410 |
Why?
| Obesity | 6 | 2018 | 2885 | 0.410 |
Why?
| Pyruvic Acid | 2 | 2024 | 53 | 0.400 |
Why?
| Mitochondria | 3 | 2024 | 875 | 0.380 |
Why?
| Uterus | 3 | 2021 | 207 | 0.380 |
Why?
| RNA, Messenger | 8 | 2016 | 2703 | 0.370 |
Why?
| Cell Proliferation | 5 | 2024 | 2378 | 0.360 |
Why?
| Oxidative Stress | 3 | 2025 | 1264 | 0.360 |
Why?
| Diet, High-Fat | 3 | 2023 | 239 | 0.350 |
Why?
| Macaca | 5 | 2018 | 54 | 0.340 |
Why?
| Receptors, Leptin | 3 | 2008 | 23 | 0.320 |
Why?
| Infusions, Intravenous | 6 | 2021 | 402 | 0.320 |
Why?
| Oxygen Consumption | 2 | 2024 | 672 | 0.310 |
Why?
| Cattle | 5 | 2016 | 978 | 0.310 |
Why?
| Gene Expression Regulation | 6 | 2020 | 2545 | 0.300 |
Why?
| Glucagon-Secreting Cells | 2 | 2024 | 24 | 0.270 |
Why?
| Up-Regulation | 4 | 2017 | 836 | 0.270 |
Why?
| Macaca mulatta | 2 | 2024 | 150 | 0.260 |
Why?
| Uterine Artery | 2 | 2024 | 78 | 0.260 |
Why?
| Gene Expression Profiling | 3 | 2019 | 1686 | 0.250 |
Why?
| Hypoglycemia | 3 | 2014 | 427 | 0.250 |
Why?
| Muscle Development | 3 | 2021 | 108 | 0.240 |
Why?
| Citrate (si)-Synthase | 2 | 2024 | 58 | 0.240 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2024 | 2444 | 0.240 |
Why?
| Muscle Fibers, Skeletal | 3 | 2021 | 203 | 0.240 |
Why?
| Sheep, Domestic | 3 | 2019 | 34 | 0.240 |
Why?
| Signal Transduction | 7 | 2024 | 4935 | 0.230 |
Why?
| Linoleic Acids, Conjugated | 1 | 2014 | 8 | 0.230 |
Why?
| Mammals | 2 | 2023 | 274 | 0.230 |
Why?
| Fatty Acids | 2 | 2023 | 427 | 0.230 |
Why?
| Glycine | 2 | 2023 | 166 | 0.220 |
Why?
| Stilbenes | 1 | 2014 | 36 | 0.220 |
Why?
| Hindlimb | 3 | 2021 | 126 | 0.220 |
Why?
| Milk | 1 | 2014 | 122 | 0.220 |
Why?
| Fetal Heart | 1 | 2024 | 55 | 0.210 |
Why?
| Mitochondria, Heart | 1 | 2024 | 94 | 0.210 |
Why?
| Pyruvates | 1 | 2023 | 24 | 0.210 |
Why?
| Macrophages | 3 | 2020 | 1489 | 0.210 |
Why?
| Muscle Proteins | 3 | 2022 | 222 | 0.210 |
Why?
| Receptors, Cytoplasmic and Nuclear | 1 | 2025 | 216 | 0.200 |
Why?
| Glutamine | 1 | 2023 | 100 | 0.200 |
Why?
| Immunophenotyping | 1 | 2024 | 310 | 0.200 |
Why?
| Serine | 1 | 2023 | 137 | 0.200 |
Why?
| Citric Acid Cycle | 2 | 2021 | 55 | 0.200 |
Why?
| Blotting, Western | 3 | 2019 | 1204 | 0.200 |
Why?
| Hypothalamus | 1 | 2003 | 148 | 0.190 |
Why?
| Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2012 | 15 | 0.190 |
Why?
| Body Temperature Regulation | 1 | 2003 | 97 | 0.190 |
Why?
| Dietary Fats | 1 | 2014 | 303 | 0.190 |
Why?
| Gene Expression | 4 | 2023 | 1465 | 0.190 |
Why?
| Myoblasts, Skeletal | 1 | 2021 | 12 | 0.190 |
Why?
| Fatty Liver | 1 | 2014 | 230 | 0.190 |
Why?
| Sympathetic Nervous System | 1 | 2012 | 174 | 0.180 |
Why?
| Quantitative Trait Loci | 1 | 2004 | 352 | 0.180 |
Why?
| Bone Marrow | 1 | 2023 | 272 | 0.180 |
Why?
| Malnutrition | 1 | 2012 | 79 | 0.180 |
Why?
| Swine | 1 | 2004 | 761 | 0.180 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2019 | 820 | 0.180 |
Why?
| Triglycerides | 2 | 2018 | 528 | 0.170 |
Why?
| Phenotype | 3 | 2023 | 3062 | 0.170 |
Why?
| Mitochondrial Diseases | 1 | 2021 | 90 | 0.170 |
Why?
| Mitochondria, Liver | 1 | 2020 | 74 | 0.170 |
Why?
| Fibrosis | 1 | 2023 | 526 | 0.170 |
Why?
| Maternal Exposure | 1 | 2021 | 177 | 0.160 |
Why?
| Chorioamnionitis | 1 | 2020 | 40 | 0.160 |
Why?
| Altitude | 1 | 2024 | 462 | 0.160 |
Why?
| Hematopoietic Stem Cells | 1 | 2023 | 382 | 0.160 |
Why?
| Male | 14 | 2025 | 63759 | 0.160 |
Why?
| Organ Size | 4 | 2021 | 456 | 0.160 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 954 | 0.160 |
Why?
| Sexual Maturation | 2 | 2008 | 52 | 0.160 |
Why?
| Glycolysis | 1 | 2021 | 314 | 0.160 |
Why?
| Protein Biosynthesis | 2 | 2017 | 406 | 0.160 |
Why?
| Acidosis | 1 | 2020 | 89 | 0.160 |
Why?
| Antioxidants | 1 | 2023 | 558 | 0.160 |
Why?
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 21 | 0.160 |
Why?
| Drug Administration Schedule | 4 | 2021 | 766 | 0.150 |
Why?
| Genomics | 1 | 2004 | 716 | 0.150 |
Why?
| STAT3 Transcription Factor | 1 | 2010 | 194 | 0.150 |
Why?
| Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2016 | 32 | 0.150 |
Why?
| Embryo, Mammalian | 1 | 2019 | 224 | 0.150 |
Why?
| Stem Cells | 1 | 2022 | 578 | 0.150 |
Why?
| Cell Division | 2 | 2017 | 790 | 0.140 |
Why?
| Anemia | 2 | 2017 | 162 | 0.140 |
Why?
| Estradiol | 2 | 2010 | 494 | 0.140 |
Why?
| Cytokines | 3 | 2014 | 2022 | 0.140 |
Why?
| Metabolic Diseases | 1 | 2018 | 104 | 0.140 |
Why?
| Oxidative Phosphorylation | 3 | 2024 | 188 | 0.140 |
Why?
| Glucose Intolerance | 1 | 2018 | 142 | 0.140 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 141 | 0.130 |
Why?
| Adiponectin | 1 | 2018 | 236 | 0.130 |
Why?
| Humans | 16 | 2024 | 129847 | 0.130 |
Why?
| Hydrocortisone | 4 | 2020 | 306 | 0.130 |
Why?
| Proteins | 1 | 2012 | 944 | 0.130 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2016 | 59 | 0.130 |
Why?
| Models, Animal | 3 | 2024 | 376 | 0.130 |
Why?
| Random Allocation | 3 | 2012 | 347 | 0.130 |
Why?
| Lower Extremity | 1 | 2019 | 407 | 0.120 |
Why?
| Lactates | 1 | 2015 | 85 | 0.120 |
Why?
| Glucose-6-Phosphatase | 3 | 2016 | 31 | 0.120 |
Why?
| Hyperglycemia | 1 | 2018 | 327 | 0.110 |
Why?
| Endocrine System Diseases | 1 | 2014 | 33 | 0.110 |
Why?
| Transcription Factors | 2 | 2014 | 1645 | 0.110 |
Why?
| Growth Hormone | 3 | 2016 | 100 | 0.110 |
Why?
| Blotting, Northern | 2 | 2004 | 196 | 0.110 |
Why?
| Infant, Newborn | 3 | 2024 | 5772 | 0.110 |
Why?
| Epithelial Cells | 2 | 2008 | 1063 | 0.100 |
Why?
| Inflammation | 2 | 2020 | 2748 | 0.100 |
Why?
| Transcriptome | 1 | 2019 | 875 | 0.100 |
Why?
| Breast Feeding | 1 | 2016 | 424 | 0.100 |
Why?
| Animal Feed | 2 | 2021 | 50 | 0.100 |
Why?
| Chromosome Mapping | 2 | 2004 | 499 | 0.100 |
Why?
| Regional Blood Flow | 2 | 2024 | 463 | 0.100 |
Why?
| Epigenesis, Genetic | 1 | 2016 | 615 | 0.090 |
Why?
| Fetal Weight | 2 | 2021 | 55 | 0.090 |
Why?
| Biomarkers | 2 | 2021 | 3971 | 0.090 |
Why?
| Mice | 6 | 2022 | 16983 | 0.090 |
Why?
| Polymerase Chain Reaction | 2 | 2004 | 1033 | 0.090 |
Why?
| Glycogen | 2 | 2016 | 55 | 0.080 |
Why?
| Mice, Obese | 2 | 2018 | 63 | 0.080 |
Why?
| Phosphorylation | 3 | 2020 | 1716 | 0.080 |
Why?
| Tissue Distribution | 2 | 2012 | 316 | 0.080 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 434 | 0.080 |
Why?
| Gastrointestinal Microbiome | 1 | 2016 | 641 | 0.080 |
Why?
| Dietary Supplements | 2 | 2014 | 532 | 0.080 |
Why?
| Inflammation Mediators | 2 | 2012 | 505 | 0.070 |
Why?
| Amino Acids, Branched-Chain | 2 | 2012 | 36 | 0.070 |
Why?
| Down-Regulation | 2 | 2017 | 631 | 0.070 |
Why?
| Animal Nutritional Physiological Phenomena | 2 | 2008 | 14 | 0.070 |
Why?
| Liver Glycogen | 2 | 2016 | 17 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2017 | 2016 | 0.070 |
Why?
| Biological Transport | 2 | 2020 | 405 | 0.060 |
Why?
| Immunity, Innate | 2 | 2023 | 804 | 0.060 |
Why?
| Lactalbumin | 1 | 2014 | 2 | 0.060 |
Why?
| Receptors, Glucagon | 1 | 2025 | 27 | 0.060 |
Why?
| Fatty Acid Synthases | 1 | 2014 | 24 | 0.060 |
Why?
| Milk Proteins | 1 | 2014 | 34 | 0.060 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 57 | 0.060 |
Why?
| RNA | 2 | 2008 | 877 | 0.060 |
Why?
| Lipogenesis | 1 | 2014 | 59 | 0.060 |
Why?
| Cell Respiration | 1 | 2024 | 98 | 0.050 |
Why?
| Contraindications | 1 | 2014 | 90 | 0.050 |
Why?
| Amniotic Fluid | 1 | 2024 | 87 | 0.050 |
Why?
| Gene Order | 1 | 2003 | 26 | 0.050 |
Why?
| Expressed Sequence Tags | 1 | 2003 | 40 | 0.050 |
Why?
| Computer Systems | 1 | 2003 | 44 | 0.050 |
Why?
| Animals, Inbred Strains | 1 | 2012 | 7 | 0.050 |
Why?
| Receptors, Neuropeptide Y | 1 | 2012 | 1 | 0.050 |
Why?
| Sympathetic Fibers, Postganglionic | 1 | 2012 | 4 | 0.050 |
Why?
| Neuropeptide Y | 1 | 2012 | 14 | 0.050 |
Why?
| Glucose Transporter Type 2 | 1 | 2012 | 12 | 0.050 |
Why?
| Ceramides | 1 | 2023 | 112 | 0.050 |
Why?
| Macrophage Activation | 1 | 2014 | 189 | 0.050 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2012 | 71 | 0.050 |
Why?
| Glucose Tolerance Test | 1 | 2014 | 355 | 0.050 |
Why?
| Cell Size | 1 | 2012 | 89 | 0.050 |
Why?
| Risk Factors | 1 | 2016 | 9801 | 0.050 |
Why?
| Electrolytes | 1 | 2012 | 59 | 0.050 |
Why?
| Hepatitis | 1 | 2012 | 47 | 0.050 |
Why?
| Solutions | 1 | 2012 | 151 | 0.050 |
Why?
| Mice, Inbred Strains | 1 | 2003 | 408 | 0.050 |
Why?
| Apoptosis | 2 | 2019 | 2489 | 0.050 |
Why?
| Acid-Base Equilibrium | 1 | 2012 | 27 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2016 | 2271 | 0.050 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2012 | 161 | 0.050 |
Why?
| Blood Gas Analysis | 1 | 2012 | 73 | 0.050 |
Why?
| Pulmonary Gas Exchange | 1 | 2012 | 121 | 0.050 |
Why?
| Mice, SCID | 1 | 2022 | 350 | 0.050 |
Why?
| Carbon Isotopes | 1 | 2012 | 127 | 0.050 |
Why?
| Time Factors | 2 | 2012 | 6550 | 0.050 |
Why?
| Forkhead Transcription Factors | 1 | 2012 | 184 | 0.050 |
Why?
| Proteolysis | 1 | 2012 | 167 | 0.050 |
Why?
| Hormones | 1 | 2012 | 140 | 0.050 |
Why?
| Infusion Pumps | 1 | 2021 | 32 | 0.050 |
Why?
| Mice, Inbred C57BL | 2 | 2018 | 5468 | 0.050 |
Why?
| Arginine | 1 | 2012 | 262 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 329 | 0.040 |
Why?
| Birth Weight | 1 | 2024 | 505 | 0.040 |
Why?
| Placentation | 1 | 2021 | 43 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 756 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2022 | 587 | 0.040 |
Why?
| Fetal Macrosomia | 1 | 2021 | 62 | 0.040 |
Why?
| Pancreatic Diseases | 1 | 2021 | 71 | 0.040 |
Why?
| Receptors, Nicotinic | 1 | 2012 | 329 | 0.040 |
Why?
| Carbon Dioxide | 1 | 2012 | 260 | 0.040 |
Why?
| Bromodeoxyuridine | 1 | 2019 | 78 | 0.040 |
Why?
| Nuclear Proteins | 1 | 2014 | 660 | 0.040 |
Why?
| Drug Synergism | 1 | 2020 | 370 | 0.040 |
Why?
| Fetal Diseases | 1 | 2021 | 164 | 0.040 |
Why?
| Pregnancy, Animal | 1 | 2019 | 53 | 0.040 |
Why?
| Body Weight | 1 | 2004 | 947 | 0.040 |
Why?
| Norepinephrine | 1 | 2020 | 209 | 0.040 |
Why?
| Alanine | 1 | 2019 | 143 | 0.040 |
Why?
| Kinetics | 1 | 2012 | 1645 | 0.040 |
Why?
| Molecular Sequence Data | 1 | 2003 | 2833 | 0.040 |
Why?
| Oncogene Protein v-akt | 1 | 2007 | 24 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2008 | 139 | 0.040 |
Why?
| Dairying | 1 | 2007 | 7 | 0.040 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 84 | 0.040 |
Why?
| Cell Count | 1 | 2018 | 318 | 0.040 |
Why?
| Chemokine CCL2 | 1 | 2008 | 117 | 0.040 |
Why?
| Receptor, Insulin | 1 | 2007 | 99 | 0.030 |
Why?
| Transcription, Genetic | 1 | 2004 | 1416 | 0.030 |
Why?
| Injections, Subcutaneous | 1 | 2007 | 146 | 0.030 |
Why?
| Caloric Restriction | 1 | 2008 | 111 | 0.030 |
Why?
| Diabetes, Gestational | 1 | 2021 | 308 | 0.030 |
Why?
| Ovariectomy | 1 | 2007 | 137 | 0.030 |
Why?
| Apolipoproteins B | 1 | 2016 | 43 | 0.030 |
Why?
| Temperature | 1 | 2019 | 635 | 0.030 |
Why?
| Cloning, Molecular | 1 | 2007 | 524 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 2020 | 872 | 0.030 |
Why?
| Kidney | 1 | 2024 | 1383 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2006 | 21 | 0.030 |
Why?
| Diet | 1 | 2014 | 1212 | 0.030 |
Why?
| Animals, Newborn | 1 | 2018 | 834 | 0.030 |
Why?
| Thyroid Hormones | 1 | 2016 | 55 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2008 | 369 | 0.030 |
Why?
| Umbilical Cord | 1 | 2016 | 83 | 0.030 |
Why?
| Exons | 1 | 2016 | 341 | 0.030 |
Why?
| Luteinizing Hormone | 1 | 2016 | 178 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2008 | 462 | 0.030 |
Why?
| Carbon Radioisotopes | 1 | 2014 | 34 | 0.030 |
Why?
| Mice, Transgenic | 1 | 2010 | 2135 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2016 | 357 | 0.030 |
Why?
| Genome | 1 | 2016 | 278 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2016 | 1092 | 0.030 |
Why?
| Receptors, Cell Surface | 1 | 2006 | 381 | 0.030 |
Why?
| Interleukin-6 | 1 | 2008 | 724 | 0.030 |
Why?
| Blood Transfusion | 1 | 2016 | 298 | 0.030 |
Why?
| Eating | 1 | 2016 | 372 | 0.030 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2008 | 1205 | 0.030 |
Why?
| Glutamic Acid | 1 | 2014 | 235 | 0.030 |
Why?
| Cells, Cultured | 1 | 2010 | 4102 | 0.020 |
Why?
| Genetic Variation | 1 | 2016 | 937 | 0.020 |
Why?
| Genotype | 1 | 2016 | 1829 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1724 | 0.020 |
Why?
| Erythrocytes | 1 | 2016 | 673 | 0.020 |
Why?
| Cell Line | 1 | 2006 | 2780 | 0.020 |
Why?
| Adult | 2 | 2024 | 35634 | 0.020 |
Why?
| Adenylate Kinase | 1 | 2009 | 26 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2016 | 2062 | 0.020 |
Why?
| Peptide Chain Initiation, Translational | 1 | 2009 | 42 | 0.020 |
Why?
| Young Adult | 1 | 2024 | 12467 | 0.020 |
Why?
| Algorithms | 1 | 2014 | 1617 | 0.020 |
Why?
| Adolescent | 1 | 2023 | 20451 | 0.010 |
Why?
|
|
Wesolowski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|